Skip to main content
WJ • RESEARCH USE ONLY

Wharton's Jelly

Minimally processed UCT Wharton's Jelly whole-tissue preparation containing an intact extracellular matrix, matrix-bound growth factors, and trace resident cells — the most complete biological tissue preparation in the Akira Biotech portfolio. Processed by gentle rinsing, mechanical trimming, and cryopreservation without decellularization, culture, or expansion, so it is best understood as an acellular-dominant, matrix-driven biologic rather than a cell-therapy product.

Intact ECM scaffold
STRUCTURAL MATRIX
— Native collagen I/III/IV/VI, fibronectin, laminin, and hyaluronic acid architecture preserved intact for mechanical cushioning and host-cell infiltration.
Matrix-bound growth factors
SLOW-RELEASE DEPOT
— TGF-β, VEGF, FGF, and HGF retained within the ECM as a localized depot rather than delivered as a bolus.
Matrix-driven, not cell-therapy
MECHANISM CLASS
— Minimally manipulated whole tissue with low, variable resident-cell viability — a distinct product category from Akira's cultured, expanded MSC injections.
ROUTES, FORMATS & APPLICATIONS
Routes
IAIntra-arterialIMIntramuscular
Quantities
150 mg cord Cells1ml
300 mg cord Cells2ml
75 mg cord, diluted with saline Cells3ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Osteoarthritis & cartilage defects
  • Tendon / ligament repair
  • Chronic wounds & burns
  • Joint injections / systemic anti-inflammatory use
  • Dental & oral surgery / alveolar bone repair
  • Facial rejuvenation & skin quality
  • Spinal disc augmentation & facet joint support
PRODUCT PROFILE

Minimally Processed Whole-Tissue Matrix

Gentle rinsing, mechanical trimming, and cryopreservation preserve the native Wharton's Jelly matrix without decellularization, culture, or expansion — delivering a structural scaffold and growth-factor depot distinct from Akira's cultured cell and exosome products.

Structural ECM scaffold
Collagens, fibronectin, laminin, and hyaluronic acid preserved intact for mechanical support and cell infiltration.
Growth factor depot
TGF-β, VEGF, FGF, and HGF physically retained within the matrix for localized, slow-release signaling.
Hydration & lubrication
Hyaluronic acid and proteoglycans (versican, aggrecan) support tissue hydration and joint lubrication.
Minimally manipulated
No decellularization, culture, or expansion — processed by rinsing, trimming, and cryopreservation only.

Compliance · Stem cells

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup